Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suma Wenfei Pingxiao Decoction Granules is a traditional Chinese medicine (TCM) herbal formulation developed by the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. It is formulated as decoction granules and is designed to warm the lungs and relieve wheezing (pingxiao) in patients with respiratory conditions. The formulation has been evaluated in a Phase 4 clinical trial in China as part of a comprehensive TCM therapy strategy for adults experiencing mild to moderate acute exacerbations of bronchial asthma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Suma Wenfei Pingxiao Decoction Granules.